Journals / Türk Yoğun Bakım Dergisi / 2022 / Cilt: 20 - Sayı: 3

Sepsis and Fibroblast Growth Factor 21: A New Acute Phase Reactant?

Sepsis ve Fibroblast Büyüme Faktörü 21: Yeni Bir Akut Faz Reaktanı mı?

Pages
132–137
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: FGF 21 can be considered an acute phase reactant in cases of infection, rising like PCT but not increasing in every acute condition.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to compare the levels of fibroblast growth factor 21 (FGF 21) in patients with acute metabolic decompensation, sepsis and non-infectious inflammatory status using infection parameters and scoring systems.
📊
Key Findings & Data:Materials and Methods: This cross-sectional study included 46 patients with sepsis and 29 patients with non-infectious inflammatory conditions in the case group.
💡
Conclusion & Impact:Conclusion: FGF 21 can be considered an acute phase reactant in cases of infection, rising like PCT but not increasing in every acute condition.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to compare the levels of fibroblast growth factor 21 (FGF 21) in patients with acute metabolic decompensation, sepsis and non-infectious inflammatory status using infection parameters and scoring systems. Materials and Methods: This cross-sectional study included 46 patients with sepsis and 29 patients with non-infectious inflammatory conditions in the case group. A total of 39 healthy volunteers were included in the control group. C-reactive protein, procalcitonin (PCT), sedimentation and FGF 21 levels were measured in all patients. Acute physiology and chronic health evaluation II and sequential organ failure assessment scores were also calculated. Results: FGF 21 levels in the patients in the case group were significantly higher than those in the patients in the control group (p˂0.001). A weak positive correlation was found between the FGF 21 and PCT levels (r=0.292, p=0.011). It was estimated that FGF 21 levels of 492.4 pg/mL and higher could predict the diagnosis of sepsis and non-infectious inflammatory status with 82.4% sensitivity and 80% specificity. Conclusion: FGF 21 can be considered an acute phase reactant in cases of infection, rising like PCT but not increasing in every acute condition.

Özet

Amaç: Bu çalışmada akut metabolik dekompanzasyon olan sepsisli ve non-enfeksiyöz enflamatuvar durumlu hastaların fibroblast büyüme faktörü 21 (FGF 21) düzeylerini, enfeksiyon parametreleri ve skorlama sistemleri ile karşılaştırmak amaçlandı. Gereç ve Yöntem: Kesitsel olarak dizayn edilen çalışmada olgu grubuna 46 sepsis tanısı olan hasta ile 29 non-enfeksiyöz enflamatuvar durum tanısı olan hasta ve kontrol grubuna da 39 sağlıklı gönüllü dahil edildi. Tüm hastaların C-reaktif protein, prokalsitonin (PCT), sedimentasyon ve FGF 21 düzey ölçümleri yapıldı. Akut fizyoloji ve kronik sağlık değerlendirmesi-II, sequential organ failure assessment skorlamaları hesaplandı. Bulgular: Sepsis ve non-enfeksiyöz enflamatuvar durum gruplarındaki FGF 21 düzeyleri, kontrol grubuna göre anlamlı olarak daha yüksek bulundu (p˂0,001). FGF 21 düzeyi ile sadece PCT düzeyi arasında zayıf pozitif bir korelasyon olduğu görüldü (r=0,292 p=0,011). FGF 21 ölçümlerinin 492,4 pg/mL ve üzerinde olmasının %82,4 sensitivite ve %80 spesifisite ile sepsis ve non-enfeksiyöz enflamatuvar durum tanılarını öngörebildiği gösterildi. Sonuç: Sonuç olarak, FGF 21, enfeksiyöz tablolarda PCT gibi yükselmesi, ancak her akut tabloda artmaması nedeni ile akut faz reaktanı olarak kabul edilmesinden dolayı şüpheli bir parametre olarak değerlendirilebilir.

🔖

Cite This Article

Deveci, S., Koca, A. O., Ertuğrul, D. T., Akkan, T., Beyan, E. (2022). Sepsis and Fibroblast Growth Factor 21: A New Acute Phase Reactant?. Türk Yoğun Bakım Dergisi, Cilt: 20 - Sayı: 3, 132–137. https://ajindex.com/articles/643375

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801-10
  2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50
  3. Genga KR, Russell JA. Update of Sepsis in the Intensive Care Unit. J Innate Immun 2017;9:441-55
  4. Li X, Zhu Z, Zhou T, Cao X, Lu T, He J, et al. Predictive value of combined serum FGF21 and free T3 for survival in septic patients. Clin Chim Acta 2019;494:31-7. 5. van Engelen TSR, Wiersinga WJ, Scicluna BP, van der Poll T. Biomarkers in Sepsis. Crit Care Clin 2018;34:139-52
  5. Marik PE. Procalcitonin is an essential biomarker for hydrocortisone, ascorbic acid, and thiamine (HAT) therapy in patients with sepsis. Crit Care 2019;23:151
  6. Suárez-Santamaría M, Santolaria F, Pérez-Ramírez A, Alemán-Valls MR, Martínez-Riera A, González-Reimers E, et al. Prognostic value of inflammatory markers (notably cytokines and procalcitonin), nutritional assessment, and organ function in patients with sepsis. Eur Cytokine Netw 2010;21:19- 26
  7. Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 2012;25:609-34
  8. Tomasiuk R, Mikaszewska-Sokolewicz M, Szlufik S, Rzepecki P, Lazowski T. The prognostic value of concomitant assessment of NT-proCNP, C-reactive protein, procalcitonin and inflammatory cytokines in septic patients. Crit Care 2014;18:440
  9. Dias AT, Matta Pde O, Nunes WA. Índices de gravidade em unidade de terapia intensiva adulto: avaliação clínica e trabalho da enfermagem [Severity indexes in an adult intensive care unit: clinical evaluation and nursing work]. Rev Bras Ter Intensiva 2006;18:276-81
  10. Luo XP, Wang HH, Hu SF, Wu SJ, Xie GH, Cheng BL, et al. [Comparison of three different organ failure assessment score systems in predicting outcome of severe sepsis]. Zhonghua Wai Ke Za Zhi 2009;47:48-50
  11. Trancă S, Petrișor C, Hagău N, Ciuce C. Can APACHE II, SOFA, ISS, and RTS Severity Scores be used to Predict Septic Complications in Multiple Trauma Patients? J Crit Care Med (Targu Mures) 2016;2:124-30
  12. Türe M, Memiş D, Kurt I, Pamukçu Z. Predictive value of thyroid hormones on the first day in adult respiratory distress syndrome patients admitted to ICU: comparison with SOFA and APACHE II scores. Ann Saudi Med 2005;25:466-72
  13. Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK,